ArticleInternational journal of dermatology2025

Prognostic Biomarkers for Anti-PD-1 Monoclonal Antibodies in the First Line Treatment of Advanced Melanoma.

Marek Pásek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.